Canopy Growth (CGC) Intangibles (2017 - 2026)
Canopy Growth (CGC) reported Intangibles of $173.1 million for Q1 2026, up 184.85% on a YoY basis from $60.8 million in Q1 2025, and up 216.94% sequentially from $54.6 million in Q4 2025.
Canopy Growth (CGC) Intangibles (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Intangibles data on file, last reported at $173.1 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles rose 184.85% year-over-year to $173.1 million; the trailing twelve-month figure through Mar 2026 stood at $173.1 million (up 184.85% YoY), and the FY2026 full-year result was $173.1 million, up 184.85% from the prior year.
- Intangibles rose to $173.1 million in Q1 2026, from $54.6 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $217.9 million in Q1 2022 to a low of $38.2 million in Q2 2025.
- A 5-year average of $122.9 million and a median of $118.9 million in 2023 frame the typical range for Intangibles.
- Across the five-year window, Intangibles tumbled 62.27% in 2024 and soared 184.85% in 2026, its largest moves.
- Tracing CGC's Intangibles over 5 years: stood at $207.5 million in 2022, then dropped by 28.95% to $147.4 million in 2023, then plunged by 56.4% to $64.3 million in 2024, then decreased by 15.03% to $54.6 million in 2025, then surged by 216.94% to $173.1 million in 2026.
- Business Quant data shows CGC's Intangibles at $173.1 million in Q1 2026, $54.6 million in Q4 2025, and $59.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 173.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173.11 Mn |
| Dec 31, 2025 | 54.62 Mn |
| Sep 30, 2025 | 58.96 Mn |
| Jun 30, 2025 | 38.21 Mn |
| Mar 31, 2025 | 60.77 Mn |
| Dec 31, 2024 | 64.28 Mn |
| Sep 30, 2024 | 148.22 Mn |
| Jun 30, 2024 | 51.38 Mn |
| Mar 31, 2024 | 77.22 Mn |
| Dec 31, 2023 | 147.41 Mn |
| Sep 30, 2023 | 110.97 Mn |
| Jun 30, 2023 | 136.19 Mn |
| Mar 31, 2023 | 118.91 Mn |
| Dec 31, 2022 | 207.47 Mn |
| Sep 30, 2022 | 210.17 Mn |
| Jun 30, 2022 | 214.09 Mn |
| Mar 31, 2022 | 217.94 Mn |
| Dec 31, 2021 | 177.69 Mn |
| Sep 30, 2021 | 184.56 Mn |
| Jun 30, 2021 | 282.35 Mn |